| View |
|
DR-XY43746
|
Gabapentin
|
Polypentin 100
|
100mg
|
Capsule
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
30 September 2019
|
24 September 2024
|
| View |
|
DR-XY43750
|
Rifampicin + Isoniazid
|
Surestep 2
|
150 mg/75 mg
|
Film Coated Tablet
|
Anti-tuberculosis
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
21 May 2024
|
25 September 2029
|
| View |
|
DR-XY43752
|
Carboxymethylcellulose (As Sodium)
|
Optear
|
5 mg/mL (0.5%)
|
Ophthalmic Solution (Eye Drops)
|
-
|
Amanta Healthcare Ltd.
|
India
|
-
|
30 September 2019
|
26 September 2024
|
| View |
|
DR-XY43753
|
Cefepime (as hydrochloride)
|
Altamax
|
1g
|
Powder For Injection (Im/Iv)
|
Antibacterial (Cephalosporin)
|
Taiwan Biotech Co., Ltd.
|
Taiwan
|
Renewal
|
05 May 2024
|
26 September 2029
|
| View |
|
DR-XY43754
|
Paracetamol
|
Paragesic
|
125 mg
|
Rectal Suppository
|
Analgesic / Antipyretic
|
Bliss GVS Pharma Ltd.
|
India
|
Renewal
|
14 June 2024
|
26 September 2029
|
| View |
|
DR-XY43755
|
Cefixime (As Trihydrate)
|
Trifix 200
|
200mg
|
Film- Coated Tablet
|
-
|
Celogen Generics Pvt. Ltd.
|
India
|
-
|
19 August 2019
|
26 September 2024
|
| View |
|
DR-XY43756
|
Gliclazide
|
None
|
30 mg
|
Modified-Release Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
11 September 2019
|
26 September 2024
|
| View |
|
DR-XY43757
|
Montelukast (As Sodium)
|
Telkast 5
|
5 mg
|
Chewable Tablet
|
-
|
MSN Laboratories Limited
|
India
|
-
|
24 September 2019
|
30 September 2024
|
| View |
|
DR-XY43759
|
Lipid Emulsion + Amino Acids + Electrolytes + Glucose
|
Combiflex Lipid Central
|
(See Attachment for Formulation)
|
Emulsion For Intravenous Infusion (IV)
|
-
|
JW Life Science Corporation
|
Korea
|
-
|
19 September 2019
|
26 September 2024
|
| View |
|
DR-XY43760
|
Lipid Emulsion + Amino Acids + Electrolytes + Glucose
|
Combiflex Lipid Peri
|
[see reverse]
|
Emulsion for IV Infusion
|
Parenteral Nutrition
|
JW Life Science Corporation
|
Korea
|
Automatic Renewal
|
24 December 2021
|
20 February 2027
|
| View |
DR-XY43762_PI_01.pdf
|
DR-XY43762
|
Meropenem (as trihydrate)
|
Natronem
|
1 g
|
Powder for Injection (IV)
|
Antibacterial
|
Samjin Pharmaceutical Co., Ltd.
|
Korea
|
Renewal
|
11 August 2024
|
29 October 2029
|
| View |
DR-XY43763_PI_01.pdf
|
DR-XY43763
|
Meropenem (As Trihydrate)
|
Natronem
|
500 mg
|
Powder for Injection (IV)
|
Antibacterial
|
Samjin Pharmaceutical Co., Ltd.
|
Korea
|
Initial (from Monitored Release)
|
04 May 2022
|
29 October 2024
|
| View |
DR-XY43764_PI_01.pdf
|
DR-XY43764
|
Axitinib
|
Inlyta
|
5 mg
|
Film-Coated Tablet
`
|
Tyrosine Kinase Inhibitor
|
Pfizer Manufacturing Deutschland GmbH
|
Germany
|
Initial (from Monitored Release status) (Correction)
|
16 May 2024
|
02 October 2024
|
| View |
DR-XY43765_PI_01.pdf
|
DR-XY43765
|
Axitinib
|
Inlyta
|
1 mg
|
Film-Coated Tablet
|
Tyrosine Kinase Inhibitor
|
Pfizer Manufacturing Deutschland GmbH
|
Germany
|
Renewal
|
06 August 2024
|
02 October 2029
|
| View |
|
DR-XY43766
|
Ceftazidime (as Pentahydrate)
|
Auromitaz 1000
|
1g
|
Powder for Injection
|
Antibacterial (Cephalosporin)
|
Aurobindo Pharma Limited
|
India
|
Automatic Renewal
|
21 September 2021
|
03 October 2026
|
| View |
|
DR-XY43773
|
Ceftazidime Pentahydrate
|
Ceftamed
|
1g
|
Powder For Injection (Iv/Im)
|
-
|
Hankook Korus Pharm. Co., Ltd.
|
Korea
|
-
|
02 July 2019
|
02 October 2024
|
| View |
|
DR-XY43774
|
Betamethasone Valerate
|
None
|
1mg/ g
|
Topical Cream
|
Corticosteroid
|
DS COSMECEUTICAL MANUFACTURING LABORATORY
|
Philippines
|
Automatic Renewal
|
06 September 2021
|
02 October 2026
|
| View |
|
DR-XY43775
|
Betamethasone (as valerate)
|
None
|
1mg/g
|
CREAM
|
Corticosteroids
|
DS Cosmeceutical Manufacturing Laboratory
|
Philippines
|
Automatic Renewal
|
31 January 2022
|
13 March 2027
|
| View |
|
DR-XY43776
|
Azithromycin (as dihydrate)
|
Aztrozin
|
500mg
|
Powder For Iv Infusion
|
Antibacterial
|
Jiangsu Kingsley Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
06 August 2024
|
02 October 2029
|
| View |
|
DR-XY43777
|
Propranolol Hydrochloride
|
Pranbeta
|
40 mg
|
Film-Coated Tablet
|
Beta-Adrenoceptor Blocker
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
28 June 2024
|
02 October 2029
|